As of August 04, 2026, Processa Pharmaceuticals's top three insider holders are David Young (Pres. Research Development, 12.11K shares), Sian Bigora (Chief Development Officer, 5.51K shares), George K Ng (Chief Executive Officer, 5.49K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Virgil Thompson | - | 0 | 708 | 24 Jul, 2023 |
| Russell Skibsted | Chief Financial Officer | 4,308 | 0 | 17 Apr, 2026 |
| Justin W Yorke | - | 0 | 3,043 | 31 Jan, 2022 |
| David Young | Pres. Research Development | 12,107 | 0 | 17 Apr, 2026 |
| James R Neal | - | 818 | 0 | 02 Apr, 2026 |
| George K Ng | Chief Executive Officer | 0 | 498 | 29 Jan, 2025 |
| James H Stanker | Chief Financial Officer | 567 | 0 | 12 Oct, 2023 |
| Khoso Baluch | - | 2,325 | 0 | 01 Apr, 2026 |
| Khalid Islam | - | 414 | 0 | 04 Apr, 2022 |
| Wendy Guy | Chief Administrative Officer | 4,693 | 0 | 17 Apr, 2026 |
| Patrick Lin | Chief Business Strategy Off | 0 | 249 | 29 Jan, 2025 |
| Sian Bigora | Chief Development Officer | 5,510 | 0 | 17 Apr, 2026 |
| Geraldine Pannu | - | 2,188 | 0 | 01 Apr, 2026 |
| Robert Michael Floyd | Chief Operating Officer | 470 | 0 | 10 Feb, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Apr, 2026 | Wendy Guy | Common Stock | A | 1,583 | $2.97 | 4,693 | D | P |
| 15 Apr, 2026 | Patrick Lin | Common Stock | A | 1,369 | $2.97 | 4,725 | D | P |
| 15 Apr, 2026 | Russell Skibsted | Common Stock | A | 1,984 | $2.97 | 4,308 | D | P |
| 15 Apr, 2026 | George K Ng | Common Stock | A | 1,843 | $2.97 | 5,492 | D | P |
| 15 Apr, 2026 | Sian Bigora | Common Stock | A | 1,799 | $2.97 | 5,510 | D | P |
| 15 Apr, 2026 | David Young | Common Stock | A | 1,545 | $2.97 | 12,107 | D | P |
| 15 Apr, 2026 | Russell Skibsted | Common Stock | A | 1,984 | $2.97 | 4,308 | D | P |
| 15 Apr, 2026 | David Young | Common Stock | A | 1,545 | $2.97 | 12,107 | D | P |
| 15 Apr, 2026 | David Young | Common Stock | A | 1,545 | $2.97 | 12,107 | D | P |
| 15 Apr, 2026 | Russell Skibsted | Common Stock | A | 1,984 | $2.97 | 4,308 | D | P |
| 31 Mar, 2026 | James R Neal | Common Stock | A | 789 | $2.54 | 818 | D | P |
| 31 Mar, 2026 | David Young | Common Stock | A | 1,810 | $2.54 | 10,562 | D | P |
| 31 Mar, 2026 | George K Ng | Common Stock | A | 2,136 | $2.54 | 3,649 | D | P |
| 31 Mar, 2026 | Khoso Baluch | Common Stock | A | 2,269 | $2.54 | 2,325 | D | P |
| 31 Mar, 2026 | David Young | Common Stock | A | 1,810 | $2.54 | 10,562 | D | P |
| 31 Mar, 2026 | David Young | Common Stock | A | 1,810 | $2.54 | 10,562 | D | P |
| 31 Mar, 2026 | Russell Skibsted | Common Stock | A | 2,324 | $2.54 | 2,324 | D | P |
| 31 Mar, 2026 | Russell Skibsted | Common Stock | A | 2,324 | $2.54 | 2,324 | D | P |
| 31 Mar, 2026 | Russell Skibsted | Common Stock | A | 2,324 | $2.54 | 2,324 | D | P |
| 31 Mar, 2026 | Patrick Lin | Common Stock | A | 1,603 | $2.54 | 3,356 | D | P |